Thursday, October 26, 2006 - (Byron J. Richards, CCN)
On October 19, 2006, the FDA fired off twenty-four warning letters to small nutrition companies that made claims they had natural remedies to help with diabetes. At first glance, one might think the FDA was actually doing its job. With tremendous bravado they announced to the world their trouncing of internet fraud. It is interesting how the FDA is now teaming up with Mexican and Canadian health authorities to attack American companies, part of the FDA’s illegal North American Union.
Thursday, October 12, 2006 - (Byron J. Richards, CCN)
The FDA has created its own monster. Could it be that an FDA advisory panel actually has enough impartial members to be truly concerned about the health and well being of all Americans? No doubt, the top FDA officials were squirming in their boots as five current and past members of the Drug Safety and Risk Management Advisory Committee went public with their call for sweeping changes at the FDA.
The October 9, 2006, issue of the Archives of Internal Medicine contains the article “FDA and Drug Safety: A Proposal for Sweeping Changes.” The lead author is Curt D. Furberg, M.D., Ph. D., an expert in epidemiology and biostatistics and current member of the FDA safety committee. He is a professor at the Department of Public Health Services, Wake Forest University School of Medicine. In an interview by Amanda Gardner, HealthDay reporter, Dr. Furberg states:
Tuesday, October 03, 2006 - (Byron J. Richards, CCN)
Americans are Injured and Killed by Drug
The next Vioxx scandal has now landed on the FDA’s plate. A secret tip to the FDA forced Bayer to admit they had failed to disclose serious safety data. Bayer scientists recently testified before an FDA advisory panel investigating the company’s heart-surgery drug, Trasylol. They failed to mention a new study Bayer commissioned for the drug, one that contained highly unfavorable results.
